EITR BIOLOGICS, INC.
SAN DIEGO, CALIFORNIA 921213221
Contract Awards
17 awards found
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
NOVEL NANOTHERAPEUTICS
NOVEL NANOTHERAPEUTICS
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS.
NOVEL NANOTHERAPEUTICS
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS.
VENEZUELAN EQUINE ENCEPHALITIS VIRUS CELL SORTING FOR MONOCLONAL ANTIBODY DISCOVERY
NOVEL NANOTHERAPEUTICS
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS.
DEVELOP A NOVEL ODIN THERAPEUTIC MEDICAL COUNTERMEASURE CAPABLE OF PROTECTING AGAINST PNEUMONIC UNENCAPSULATED Y. PESTIS.
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
SORTING PERIPHERAL BLOOD MONONUCLEAR CELLS FROM LASSA FEVER VIRUS SURVIVORS TO DISCOVER AND PRODUCE MONOCLONAL ANTIBODIES FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
VENEZUELAN EQUINE ENCEPHALITIS VIRUS CELL SORTING FOR MONOCLONAL ANTIBODY DISCOVERY
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
NOVEL NANOTHERAPEUTIC APPROACHES PENETRATING THE OUTER LAYERS OF THE BACTERIUM AND TARGETING OUTER MEMBRANE PROTEINS FOR THE TREATMENT OF PNEUMONIC PLAGUE FOR ASSESSMENT IN IN VITRO AND IN VIVO ASSAYS
NOVEL CELL SORTING
NOVEL CELL SORTING
Business Details
- UEI
- HX49LZLY32G5
- CAGE Code
- 99JH0
- Address
- 6555 NANCY RIDGE DR STE 300
SAN DIEGO, CA 921213221 - Congressional District
- CA-51
- Phone
- 8589996764
Parent Company
EITR BIOLOGICS, INC.
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov